State Street Corp Cara Therapeutics, Inc. Transaction History

State Street Corp

$2.21 Trillion
Q1 2024

A detailed history of State Street Corp transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 1,002,954 shares of CARA stock, worth $330,974. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,002,954

Previous 1,020,878 1.76%

Holding current value

$330,974

Previous $755,000 20.79%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.52 - $1.05 $9,320 - $18,820	-17,924 Reduced 1.76%	1,002,954 $912,000
Q4 2023 Feb 14, 2024	BUY	$0.6 - $1.65 $57,364 - $157,753	95,608 Added 10.33%	1,020,878 $755,000
Q3 2023 Nov 14, 2023	BUY	$1.67 - $3.33 $9,706 - $19,353	5,812 Added 0.63%	925,270 $1.55 Million
Q2 2023 Aug 14, 2023	SELL	$2.83 - $4.94 $2.78 Million - $4.86 Million	-983,484 Reduced 51.68%	919,458 $2.6 Million
Q1 2023 May 15, 2023	BUY	$4.89 - $12.27 $617,210 - $1.55 Million	126,219 Added 7.1%	1,902,942 $9.34 Million

Q4 2022 Feb 14, 2023	SELL	$8.88 - $12.77 $903,184 - $1.3 Million	-101,710 Reduced 5.41%	1,776,723 $19.1 Million
Q3 2022 Nov 15, 2022	SELL	$8.24 - $12.56 $627,171 - $955,979	-76,113 Reduced 3.89%	1,878,433 $17.6 Million
Q2 2022 Aug 15, 2022	BUY	$7.45 - $13.84 $2.04 Million - $3.79 Million	273,947 Added 16.3%	1,954,546 $17.8 Million
Q1 2022 May 16, 2022	BUY	$9.94 - $12.65 $1.83 Million - $2.33 Million	184,099 Added 12.3%	1,680,599 $20.4 Million
Q4 2021 Feb 14, 2022	SELL	$11.99 - $18.14 $91,915 - $139,061	-7,666 Reduced 0.51%	1,496,500 $18.2 Million
Q3 2021 Nov 15, 2021	SELL	$11.55 - $16.06 $1.31 Million - $1.82 Million	-113,612 Reduced 7.02%	1,504,166 $23.2 Million
Q2 2021 Aug 16, 2021	BUY	$12.38 - $29.19 $8.63 Million - $20.3 Million	696,893 Added 75.68%	1,617,778 $23.1 Million
Q1 2021 May 17, 2021	SELL	$15.07 - $21.71 $627,876 - $904,525	-41,664 Reduced 4.33%	920,885 $20 Million
Q4 2020 Feb 16, 2021	BUY	$12.72 - $16.16 $165,563 - $210,338	13,016 Added 1.37%	962,549 $14.6 Million
Q3 2020 Nov 10, 2020	SELL	$12.34 - $17.92 $652,539 - $947,609	-52,880 Reduced 5.28%	949,533 $12.1 Million
Q2 2020 Aug 14, 2020	SELL	$12.39 - $17.33 $231,160 - $323,325	-18,657 Reduced 1.83%	1,002,413 $17.1 Million
Q1 2020 May 11, 2020	BUY	$9.12 - $17.78 $9.31 Million - $18.2 Million	1,021,070 New	1,021,070 $13.5 Million

Others Institutions Holding CARA

# of Institutions

102

Shares Held

21.5M

Call Options Held

50K

Put Options Held

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $17.7M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Cara Therapeutics, Inc. Transaction History